@book{35c78b3dd18b485b8431cbd56a4c1b53,
title = "Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways",
abstract = "This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.",
editor = "Yosef Yarden and Moshe Elkabets",
note = "notValidatingIssn:2196-5501 ;",
year = "2018",
doi = "10.1007/978-3-319-67932-7",
language = "English",
isbn = "9783319679303",
series = "Resistance to Targeted Anti-Cancer Therapeutics",
publisher = "Springer",
address = "Germany",
edition = "1st ed. 2018",
}